In March 2025, the company introduced new options to get a immediate-to-consumer giving of its Wegovy weight loss drug. The company recognized a completely new pharmacy, referred to as NovoCare, which would cost consumers $499 per 30 days for access to the drug, less than fifty percent the expense of the drug via other pharmaceutical distribution n